House Hearings 2008

SBIR: Advancing Medical Breakthroughs Statement of Jo Anne Goodnight, SBIR/STTR Program Coordinator, National Institutes of Health, U.S. Department of Health and Human Services

Committee Calls for Sweeping Reforms to SBIR Program

House Subcommittee Examines the Role of SBIR in Fostering Medical Breakthroughs

Hearing Testimony

Douglas A. Doerfler, President and CEO MaxCyte, Inc.

Michael Borrus, Founding General Partner, X/Seed Capital

Honorable Amy Comstock Rick, J.D., CEO Parkinson’s Action Network

Melvin Billingsley, Ph.D., President and CEO, Life Sciences Greenhouse of Central Pennsylvania

F. Nicholas Franano, M.D., Founder and Chief Scientific Officer, Proteon Therapeutics, Inc.

Statements

Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation

James Stefansic, Ph.D., MBA, Chief Technology Officer, Pathfinder Therapeutics, Inc.

Leave a Reply